PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this extended study is to collect confirmatory safety and effectiveness data on the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in the treatment of aortoiliac and iliac aneurysms.

Official Title

Clinical Study to Collect Confirmatory Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * An aortoiliac or iliac aneurysm of appropriate size* Unsuitable distal sealing site for a traditional Zenith® iliac leg graft within the common iliac artery
Exclusion Criteria:
  1. * Less than 18 years of age* Inability or refusal to give informed consent* Disease considerations that would compromise patient safety or study outcomes* Unsuitable arterial anatomy


Jason T. Lee, MD
Jason T. Lee, MD
Vascular surgeon
Professor of Surgery (Vascular Surgery)